The humanistic and economic burden of atopic dermatitis among adults and adolescents in Saudi Arabia
Creators: name: Elezbawy, Baher
name: Fasseeh, Ahmad Nader
name: Fouly, Essam
name: Abu Esba, Laila Carolina
name: Al Abdulkarim, Hana
name: Al-Haddab, Mohammed
name: Al-Sheikh, Afaf
name: Altawil, Esraa
name: Al Turaiki, Abdulrahman
name: Eshmawi, Maysa
name: Hamadah, Issam
name: Tannira, Mohamed
name: Dalle, Hala
name: Aderian, Sandrine
name: Roshdy, Ahmed
name: Jaheen, Ahmed
name: Hamad, Tharwat
name: Abaza, Sherif
name: Kaló, Zoltán
Publisher: name: Taylor & Francis
Year: 2022
Subjects: subject: Medicine
subject: Biotechnology
subject: Sociology
subject: FOS: Sociology
subject: Biological Sciences not elsewhere classified
subject: Science Policy

description: <b><i>Aims:</i></b> Atopic dermatitis (AD) is a chronic skin disease that creates a significant burden to patients and society. There is scarcity in local data about the burden of AD in the Kingdom of Saudi Arabia (KSA). We aimed to fill in this gap and quantify the humanistic and economic burden of AD among adults and adolescents in KSA. <b><i>Materials and Methods:</i></b> A literature search and local expert interviews were conducted to assess the disease burden. Prevalence values were estimated through the literature. International data about health-related quality of life lost owing to AD was adjusted to age and prevalence in KSA. Direct and indirect costs were calculated using a bottom-up approach. Resource utilization data were collected from local dermatologists through online interviews, and indirect costs were based on absenteeism and presenteeism estimates. Validation meetings were conducted with local experts to adjust the final estimates. <b><i>Results:</i></b> The age-standardized health loss per patient due to AD is 0.187 quality-adjusted life-years (QALYs) annually, aggregating to 64 thousand lost QALYs in KSA. The annual average direct cost for a patient with AD was 2924 Saudi Riyal (SAR; 780 USD), totaling 373 million SAR in KSA (99.5 million USD). This value represents 0.2% of the annual health expenditure in KSA. The total productivity loss due to AD was 1.36 billion SAR (363.7 million USD). Overall, the economic burden of AD consumes up to 0.059% of the national gross domestic product. <b><i>Limitations:</i></b> Local quality of life and productivity lost data were not available for KSA, so global averages were used, assuming these numbers also apply to KSA. <b><i>Conclusion:</i></b> Indirect costs represent a large proportion of AD burden in KSA. The disease has a substantial effect on patient quality of life and social well-being. Alleviating the burden might result in significant savings in resources to society. Atopic dermatitis is one of the most common skin diseases. Mild cases of the disease cause inflamed and itchy skin, while severe cases may cause painful episodes of itching and cracked skin. Patients with atopic dermatitis and their families suffer lower quality of life as the severity of the disease increases. In countries with hot weather like Saudi Arabia, skin is more susceptible to become dry, so the disease is very prevalent. Therefore, the disease poses a significant quality of life burden as well as an economic burden due to the direct costs of treatment and the indirect costs that arise because patients become non-productive or absent from work or school. Our study aimed to quantify the economic and quality of life burden of atopic dermatitis in Saudi Arabia to understand it’s real burden and help decision makers quantify its impact on the patients and society. We conducted a literature search and interviewed local experts to determine estimates of costs and quality of life effects. The results of this study should help in prioritizing treatment disease areas in Saudi Arabia and other countries with similar circumstances.